anti-ARD1 Homolog, N-Acetyltransferase (ARD1A) Anticorps

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. De plus, nous expédions ARD1 Homolog, N-Acetyltransferase Protéines (9) et ARD1 Homolog, N-Acetyltransferase Kits (3) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
ARD1A 8260 P41227
ARD1A 56292 Q9QY36
ARD1A 363518  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-ARD1 Homolog, N-Acetyltransferase Anticorps sur anticorps-enligne.fr

Showing 10 out of 50 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-ARD1A Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:312500  Positive Control:  Human heart 100 μL 2 to 3 Days
$289.00
Détails
Roussette (Chauve-souris) Lapin Inconjugué WB 100 μL 11 to 14 Days
$551.83
Détails
Humain Lapin Inconjugué IF/ICC, IHC, WB Western blot analysis of extracts of various cell lines, using NAA10 antibody (ABIN5974216) at 1/1000 dilution. Immunohistochemistry of paraffin-embedded rat lung using NAA10 antibody (ABIN5974216) at dilution of 1/100 (40x lens). 100 μL 11 to 16 Days
$426.40
Détails
Humain Lapin Inconjugué IF, IHC, WB Western blot analysis of extracts of various cell lines, using NAA10 antibody. Immunohistochemistry of paraffin-embedded rat lung using NAA10 antibody. 200 μL 12 to 14 Days
$438.90
Détails
Humain Souris Inconjugué ELISA, ICC, WB Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng) Western blot analysis using NAA10 mAb against human NAA10 (AA: 111-235) recombinant protein. (Expected MW is 47.2 kDa) 0.1 mg 3 to 4 Days
$430.10
Détails
Humain Souris Inconjugué ELISA, FACS, ICC, WB Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng) Western blot analysis using NAA10 mAb against human NAA10 (AA: 111-235) recombinant protein. (Expected MW is 47.2 kDa) 0.1 mg 3 to 4 Days
$430.10
Détails
Humain Lapin Inconjugué WB Western Blot at 1:2000 dilution Lane 1: SK-BR-3 whole cell lysate Lane 2: Hela whole cell lysate Lane 3: HCT116 whole cell lysate Lane 4: MCF-7 whole cell lysate Lane 5: HL-60 whole cell lysate Lysates/proteins at 20 ug per lane. 200 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué ELISA, WB 100 μL 2 to 3 Days
$446.88
Détails
Humain Lapin Inconjugué IHC (p), IP, ELISA, WB Human ARD1 Immunohistochemistry(IHC) 7814 Human ARD1 Western blot (WB) 13573 100 μL 14 to 16 Days
$247.82
Détails
Humain Poulet Inconjugué WB 0.05 mg 2 to 3 Days
$481.25
Détails

anti-ARD1 Homolog, N-Acetyltransferase Anticorps mieux référencés

  1. Human Polyclonal ARD1A Primary Antibody pour ELISA - ABIN563573 : Azizi, Li, Ströbel, Chen, Slavc, Lubec: Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med. dans Amino acids 2012 (PubMed)

  2. Human Polyclonal ARD1A Primary Antibody pour ICC, IF - ABIN4337709 : Simsek, Tiu, Flynn, Byeon, Leppek, Xu, Chang, Barna: The Mammalian Ribo-interactome Reveals Ribosome Functional Diversity and Heterogeneity. dans Cell 2017 (PubMed)

Plus d’anticorps contre ARD1 Homolog, N-Acetyltransferase partenaires d’interaction

Human ARD1 Homolog, N-Acetyltransferase (ARD1A) interaction partners

  1. Data suggest a model where reduced N(alpha)-acetyltransferase 10 N(alpha)-acetyltransferase 10, NatA catalytic subunit (NAA10) activity cause the phenotypes observed in the two patients.

  2. Data show that N-alpha-acetyltransferase 10 (NAA10) as a factor in the transcriptional machinery regulating pregnaneXreceptor (PXR) transcription.

  3. Higher NAA10 transcripts were observed in metastatic osteosarcoma tissues and correlated with worse prognosis. Its knockdown and overexpression in osteosarcoma cells respectively led to decreased and increased cell migratory/invasive abilities. Naa10p was directly associated with MMP-2 protein through its acetyltransferase domain maintaining MMP-2 protein stability.

  4. Results show that NAA10 active site is regulated by HYPK inhibiting the activity of N-terminal acetyltransferases A.

  5. A novel NAA10 mutation was identified in three cases of developmental delay, intellectual disability, and hypertrophic cardiomyopathy. Pathogenic NAA10 variant impaired acetyltransferase activity and stability.

  6. Since the FIH-1 dependent hydroxylation of NAA10 occurs oxygen-dependently, NAA10 acetylates HIF-1alpha under normoxia but does not under hypoxia.

  7. In combination with acetylation assays, the HypK N-terminal region is identified as a negative regulator of the NatA acetylation activity

  8. ARD1-mediated Hsp70 acetylation is a regulatory mechanism that temporally balances protein refolding/degradation in response to stress

  9. Negative regulation of Naa10 towards NTN1 and its receptor UNC5B were also detected upon treatment of all-trans retinoid acid, which was often used to induce morphological differentiation.

  10. A novel de novo NAA10 c.332 T>G p.(Val111Gly) missense variant was detected in a girl with mild/moderate non-syndromic intellectual disability. NAA10 V111G displayed reduced monomeric NAT activity and stability, but intact NatA-mediated NAT activity.

  11. Expression of ARD1 increases levels of androgen receptor acetylation and androgen receptor-HSP90 dissociation in a dose dependent manner.

  12. Study reports on a total of 12 affected females with four different de novo missense mutations in NAA10 and one inherited mutation in a familial case due to germline mosaicism, thus further expanding themutational and clinical spectrum associated with NAA10 related N-terminal-acetyltransferase deficiency.

  13. our study illustrated that the expression of Naa10p had a potential value for predicting the progression of OSCC and prognosis of OSCC patients.

  14. The results observed an inverse correlation between the expression of NAA10 and that of miR-342-5p and miR-608 .

  15. Human Naa15 (NATH) and Naa10 (ARD1) form a stable NatA complex which associates with ribosomes and performs co-translational N-terminal acetylation; Naa15 (NATH) and Naa10 (ARD1) are cleaved during apoptosis resulting in decreased acetyltransferase activity

  16. The clinical spectrum of NAA10.

  17. there is no difference in lysine acetylation of substrate proteins with or without Naa10, suggesting that the substrates may be acetylated chemically rather than enzymatically.

  18. Combined high expression of Naa10p, SNCG and PRL-3 are associated with lymph node metastasis in breast cancer.

  19. De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females

  20. human ARD1 variants have different effects on cell proliferation, which may result from distinct subcellular localizations and autoacetylation activities.

Mouse (Murine) ARD1 Homolog, N-Acetyltransferase (ARD1A) interaction partners

  1. we established Naa10 knockout mESCs to test this hypothesis. We found that Naa10 deficiency attenuated differentiation towards the epiblast lineage, deviating towards primitive endoderm.

  2. Negative regulation of Naa10 towards NTN1 and its receptor UNC5B were also detected upon treatment of all-trans retinoid acid, which was often used to induce morphological differentiation.

  3. The lethal Ogden syndrome-associated mutation of Naa10p disrupts its binding to the imprinting control region of H19 and Dnmt1 recruitment.

  4. NAA10 acts as a guard ensuring balanced osteogenesis by fine-tuning Runx2 signalling in a feedback manner.

  5. ARD1 has a crucial role in the cellular response to oxidative stress as a bona fide regulator of MSRA.

  6. mARD1A(225) may be a novel upstream target that blocks VEGFA expression and tumor-related angiogenesis.

  7. Biochemical analysis demonstrated that mNAT1 and its evolutionarily conserved co-subunit, mARD1, assemble to form a functional acetyltransferase.

  8. Mouse ortholog (225) of ARD1 strongly decreased the level of hypoxia inducible factor (HIF)-1 alpha and increased the extent of acetylation, whereas mARD1(235) variants had a much weaker effect on HIF-1 alpha stability and acetylation.

  9. These results indicate that ARD1(235) and ARD1(225) isoforms may have different activities and function in different subcellular compartments of mammalian cells.

ARD1 Homolog, N-Acetyltransferase (ARD1A) profil antigène

Profil protéine

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants.

Gene names and symbols associated with ARD1A

  • N(alpha)-acetyltransferase 10, NatA catalytic subunit (NAA10) anticorps
  • N(alpha)-acetyltransferase 10, NatA catalytic subunit (Naa10) anticorps
  • 2310039H09Rik anticorps
  • Ard1 anticorps
  • Ard1a anticorps
  • DXS707 anticorps
  • NATD anticorps
  • RGD1565315 anticorps
  • Te2 anticorps

Protein level used designations for ARD1A

ARD1 homolog A, N-acetyltransferase , N-acetyltransferase ARD1, human homolog of , N-alpha-acetyltransferase 10 , N-alpha-acetyltransferase 10, NatA catalytic subunit , N-terminal acetyltransferase complex ARD1 subunit homolog A , alpha-N-acetyltransferase 1A , natA catalytic subunit , N-acetyltransferase ARD1 , N(alpha)-acetyltransferase 10, NatA catalytic subunitNalpha acetyltransferase 10 , N-acetyltransferase ARD1 homolog , Nalpha acetyltransferase 10

GENE ID SPECIES
8260 Homo sapiens
613636 Bos taurus
100328748 Oryctolagus cuniculus
56292 Mus musculus
363518 Rattus norvegicus
Fournisseurs de qualité sélectionnés pour anti-ARD1 Homolog, N-Acetyltransferase (ARD1A) Anticorps
Avez-vous cherché autre chose?